Xin Tao is a member of Baker McKenzie's North America Steering Committee for Healthcare & Life Sciences, and chairs our US Healthcare and Life Science Regulatory Practice. Clients describe Xin as "His dedication to his clients stands out; he goes above and beyond to do whatever we need. He's really pragmatic with his advice too."(Chambers USA Client Interview - 2024). As a seasoned US life science counsel, and a former research scientist, Xin works closely with global companies with novel pharmaceutical, medical device, food, and cosmetic applications that require US government's pre-market approval or clearance and FDA Current Good Manufacturing Practices (cGMP) compliance. Xin has extensive experience advising both emerging and established companies on the strategy with launching and promoting innovative products, including AI-empowered applications. Closely working with our life science transaction and IP licensing team, Xin also draws on his expertise and experience to provide clients with practical advice regarding cross- border life science collaboration and transactions.